The 10,000-Step Lie and the Real Threshold
The 10,000-step recommendation is not a medical guideline. It is a marketing slogan — one that originated in the 1960s when a Japanese pedometer manufacturer needed a catchy name for its device. The number sounds round, sells well, and has stubbornly lodged itself in minds and apps ever since. It never had a scientific foundation.
A meta-analysis published in summer 2025 in The Lancet Public Health now sets a different threshold. Better supported, more clinically relevant, and far more motivating for your sedentary clients.
What the Study Did
Ding et al. from the University of Sydney systematically analysed 57 prospective studies covering the period 2014 to 2025. The dataset includes adults of all age groups from more than ten countries. One methodological detail that strengthens the findings: step counts were recorded using device-based measurement, not self-reported questionnaires. This substantially reduces recall bias.
The authors examined step counts against eight hard endpoints:
- All-cause mortality
- Cardiovascular incidence and mortality
- Cancer mortality
- Type 2 diabetes
- Dementia
- Depression
- Falls
No soft surrogate markers, no self-assessment. Outcomes that matter in practice.
The Findings
The clinically relevant benefit largely plateaus at around 7,000 steps per day. Compared to a baseline of 2,000 steps daily, the following risk reductions were observed:
Endpoint Risk Reduction All-cause mortality minus 47 percent Cardiovascular mortality minus 47 percent Cancer mortality minus 37 percent Dementia minus 38 percent Falls minus 28 percent Depressive symptoms minus 22 percent Type 2 diabetes minus 14 percentThe authors note: for physically active individuals, a target of 10,000 steps remains worthwhile. But 7,000 is the point at which the majority of measurable benefit has already been achieved. Attainable in everyday life, without structured training. That is the message that can genuinely take hold in client conversations.
The Underestimated Jump at the Bottom
The strategically most important finding of the study is not at 7,000. It sits lower.
Moving from 2,000 to 4,000 steps per day already produces a substantial reduction in mortality risk. The dose-response curve is not linear. It is steepest precisely where most of your sedentary clients are today.
This has a concrete implication for practice: movement does not need to be ambitious to be effective. It needs to be compatible with everyday life. A first step from 2,000 to 4,000 is a walk after lunch, not a training plan. And the effect is real.
For clients who quickly feel overwhelmed by large goals, this is a different way into the conversation.
Why Walking Has Such Broad Effects
Walking is the form of movement for which the human body has been evolutionarily optimised over millions of years. No other pattern of physical activity is so deeply encoded in our physiology.
This explains why such a simple everyday activity acts on so many endpoints simultaneously. Walking activates multiple systems in parallel:
- Microcirculation: Improved blood flow in the periphery
- Systemic inflammation: Reduction of pro-inflammatory markers
- Glucose-insulin axis: Stabilisation of the postprandial glucose profile
- Autonomic nervous system: Parasympathetic calming, measurable via heart rate variability
- Neuroplasticity: BDNF release in the hippocampus, relevant for cognitive function and mood
No single pathway dominates. It is the breadth of effect that explains why a step-count intervention produces simultaneous effects on dementia, depression, diabetes, and mortality. This is not an oversimplification. It is systems biology.
Where SLOW Is Headed with This
This is precisely where an evidence-based support approach differs from an app recommendation.
Thought holistically: A step recommendation never works in isolation. It reaches into sleep architecture, stress load, glucose curve, mood, and heart rate variability. Pulling the walking lever shifts multiple systems in parallel. That is what makes the intervention so densely effective. It also makes clear why a standalone step-counter app does not unlock the full potential of this intervention.
Applied precisely: The 7,000-step threshold is a population-based average. In practice, it depends on age, pre-existing conditions, and training status. Actigraphy, cardiorespiratory markers, daily glucose profiles, and individual progression determine where the personal sweet spot lies. For a 68-year-old client with type 2 diabetes and limited heart rate reserve, the optimum looks different than it does for a 42-year-old practitioner client with a sleep deficit and stress load.
On the SLOW platform, health professionals translate exactly this data into support that fits the individual. The 10,000-step myth becomes a personally sustainable, measurably effective goal. From data to results.
Conclusion
7,000 steps is the evidence-based threshold at which clinically relevant benefit is largely achieved for most adults. The greatest effect occurs at the lower end: the jump from 2,000 to 4,000 steps is the single most effective measure you can recommend for sedentary clients.
The 10,000-step figure was never a recommendation. It was a product name. It is time to correct that in practice.
What step threshold do you find realistically achievable in practice — and how do you measure the quality and intensity of movement alongside the raw step count? Share your thoughts in the comments.